Definitive Healthcare Corp (DH) Stock Forecast & Price Target

Compare

68 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

DH Analyst Ratings

Hold

2 Buy

4 Hold

1 Sell

Based on 7 analysts giving stock ratings to

Definitive

Healthcare Corp

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

DH Stock 12 Month Forecast

Average Price Target

$4.50

▲(9.76%Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Definitive Healthcare Corp in the last 3 months. The average price target is $4.50 with a high forecast of $5.00 and a low forecast of $3.00. The average price target represents a 9.76% change from the last price of $4.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","3":"$3","5":"$5","7":"$7","9":"$9"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,3,5,7,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.05,4.123076923076923,4.196153846153846,4.269230769230769,4.342307692307692,4.415384615384616,4.4884615384615385,4.561538461538461,4.634615384615385,4.707692307692308,4.780769230769231,4.853846153846154,4.926923076923077,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.05,4.084615384615384,4.119230769230769,4.153846153846153,4.188461538461539,4.223076923076923,4.257692307692308,4.292307692307692,4.326923076923077,4.361538461538461,4.3961538461538465,4.430769230769231,4.4653846153846155,{"y":4.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.05,3.969230769230769,3.8884615384615384,3.8076923076923075,3.726923076923077,3.646153846153846,3.565384615384615,3.4846153846153847,3.4038461538461537,3.323076923076923,3.2423076923076923,3.1615384615384614,3.0807692307692305,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.97,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.97,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.37,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.69,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.18,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.74,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.11,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.86,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.23,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.64,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.75,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.05,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$5.00

Average Price Target$4.50

Lowest Price Target$3.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$4.5

Hold

9.76%

Upside

Reiterated

07/09/25

Definitive Healthcare Corp has strong technical momentum and positive earnings call insights, but faces challenges with profitability and valuation. The company's financial structure is stable, yet under pressure, necessitating improvements in cost efficiency and profitability to enhance its overall score.

Saket KaliaBarclays

Barclays

Sell

-26.83%

Downside

Reiterated

05/09/25

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF), Natera (NASDAQ: NTRA) and Definitive Healthcare Corp (NASDAQ: DH)

David GrossmanStifel Nicolaus

Stifel Nicolaus

$6→$5

Buy

21.95%

Upside

Reiterated

05/09/25

Stifel Nicolaus Remains a Buy on Definitive Healthcare Corp (DH)

Ryan MacDonaldNeedham

Needham

―

Hold

―

Reiterated

05/09/25

Cautious Hold Rating for Definitive Healthcare Corp Amid Promising Developments and Retention Concerns

Craig HettenbachMorgan Stanley

Morgan Stanley

Hold

21.95%

Upside

Reiterated

05/09/25

Definitive Healthcare Corp: Hold Rating Amid Positive Developments and Market Challenges

David HynesCanaccord Genuity

Canaccord Genuity

Hold

21.95%

Upside

Reiterated

05/09/25

Definitive Healthcare Corp: Stabilization Amidst Challenges Warrants Hold Rating

Ryan DanielsWilliam Blair

William Blair

―

Buy

―

Reiterated

05/08/25

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH) and Silence Therapeutics (NASDAQ: SLN)

David LarsenBTIG

BTIG

―

Hold

―

Downgraded

05/08/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (NASDAQ: TKNO), Definitive Healthcare Corp (NASDAQ: DH) and Wave Life Sciences (NASDAQ: WVE)

Joseph VruwinkRobert W. Baird

Robert W. Baird

$5→$3

Hold

-26.83%

Downside

Reiterated

04/08/25

Definitive Healthcare Corp (DH) PT Lowered to $3 at BairdBaird analyst Joe Vruwink lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $3.00 (from $5.00) while maintaining a Neutral rating.

Kash RanganGoldman Sachs

Goldman Sachs

$4.5→$3

Hold

-26.83%

Downside

Reiterated

03/04/25

Definitive Healthcare Corp (DH) PT Lowered to $3 at Goldman SachsGoldman Sachs analyst Kash Rangan lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $3.00 (from $4.50) while maintaining a Neutral rating.

Jeffrey GarroStephens

Stephens

Hold

21.95%

Upside

Initiated

12/19/24

Definitive Healthcare initiated with an Equal Weight at StephensDefinitive Healthcare initiated with an Equal Weight at Stephens

George HillDeutsche Bank

Deutsche Bank

$7→$5

Hold

21.95%

Upside

Reiterated

08/08/24

Definitive Healthcare price target lowered to $5 from $7 at Deutsche BankDefinitive Healthcare price target lowered to $5 from $7 at Deutsche Bank

Allen LutzBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

07/31/24

Bank of America Securities Keeps Their Buy Rating on Definitive Healthcare Corp (DH)

Anne SamuelJ.P. Morgan

J.P. Morgan

$7→$5

Sell

21.95%

Upside

Downgraded

07/31/24

Definitive Healthcare downgraded to Underweight from Neutral at JPMorganDefinitive Healthcare downgraded to Underweight from Neutral at JPMorgan

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$4.5

Hold

9.76%

Upside

Reiterated

07/09/25

Saket KaliaBarclays

Barclays

Sell

-26.83%

Downside

Reiterated

05/09/25

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF), Natera (NASDAQ: NTRA) and Definitive Healthcare Corp (NASDAQ: DH)

David GrossmanStifel Nicolaus

Stifel Nicolaus

$6→$5

Buy

21.95%

Upside

Reiterated

05/09/25

Stifel Nicolaus Remains a Buy on Definitive Healthcare Corp (DH)

Ryan MacDonaldNeedham

Needham

―

Hold

―

Reiterated

05/09/25

Cautious Hold Rating for Definitive Healthcare Corp Amid Promising Developments and Retention Concerns

Craig HettenbachMorgan Stanley

Morgan Stanley

Hold

21.95%

Upside

Reiterated

05/09/25

Definitive Healthcare Corp: Hold Rating Amid Positive Developments and Market Challenges

David HynesCanaccord Genuity

Canaccord Genuity

Hold

21.95%

Upside

Reiterated

05/09/25

Definitive Healthcare Corp: Stabilization Amidst Challenges Warrants Hold Rating

Ryan DanielsWilliam Blair

William Blair

―

Buy

―

Reiterated

05/08/25

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH) and Silence Therapeutics (NASDAQ: SLN)

David LarsenBTIG

BTIG

―

Hold

―

Downgraded

05/08/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (NASDAQ: TKNO), Definitive Healthcare Corp (NASDAQ: DH) and Wave Life Sciences (NASDAQ: WVE)

Joseph VruwinkRobert W. Baird

Robert W. Baird

$5→$3

Hold

-26.83%

Downside

Reiterated

04/08/25

Kash RanganGoldman Sachs

Goldman Sachs

$4.5→$3

Hold

-26.83%

Downside

Reiterated

03/04/25

Jeffrey GarroStephens

Stephens

Hold

21.95%

Upside

Initiated

12/19/24

Definitive Healthcare initiated with an Equal Weight at StephensDefinitive Healthcare initiated with an Equal Weight at Stephens

George HillDeutsche Bank

Deutsche Bank

$7→$5

Hold

21.95%

Upside

Reiterated

08/08/24

Definitive Healthcare price target lowered to $5 from $7 at Deutsche BankDefinitive Healthcare price target lowered to $5 from $7 at Deutsche Bank

Allen LutzBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

07/31/24

Bank of America Securities Keeps Their Buy Rating on Definitive Healthcare Corp (DH)

Anne SamuelJ.P. Morgan

J.P. Morgan

$7→$5

Sell

21.95%

Upside

Downgraded

07/31/24

Definitive Healthcare downgraded to Underweight from Neutral at JPMorganDefinitive Healthcare downgraded to Underweight from Neutral at JPMorgan

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Definitive Healthcare Corp

1 Month

xxx

Success Rate

8/14 ratings generated profit

Average Return

+2.08%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +2.08% per trade.

3 Months

xxx

Success Rate

7/14 ratings generated profit

Average Return

-10.40%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -10.40% per trade.

1 Year

David GrossmanStifel Nicolaus

Success Rate

4/14 ratings generated profit

Average Return

-27.51%

reiterated a buy rating 3 months ago

Copying David Grossman's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -27.51% per trade.

2 Years

xxx

Success Rate

4/14 ratings generated profit

Average Return

-34.16%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -34.16% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DH Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, DH has received 2 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. DH average Analyst price target in the past 3 months is 4.50.

Each month's total comprises the sum of three months' worth of ratings.

DH Financial Forecast

DH Earnings Forecast

Next quarter’s earnings estimate for DH is $0.05 with a range of $0.05 to $0.05. The previous quarter’s EPS was $0.05. DH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.90% of the time in the same period. In the last calendar year DH has Outperformed its overall industry.

DH Sales Forecast

Next quarter’s sales forecast for DH is $59.24M with a range of $58.64M to $59.55M. The previous quarter’s sales results were $59.19M. DH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.29% of the time in the same period. In the last calendar year DH has Outperformed its overall industry.

DH Stock Forecast FAQ

What is DH’s average 12-month price target, according to analysts?

Based on analyst ratings, Definitive Healthcare Corp. Class A’s 12-month average price target is 4.50.

What is DH’s upside potential, based on the analysts’ average price target?

Definitive Healthcare Corp. Class A has 9.76% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is DH a Buy, Sell or Hold?

Definitive Healthcare Corp. Class A has a consensus rating of Hold which is based on 2 buy ratings, 4 hold ratings and 1 sell ratings.

What is Definitive Healthcare Corp. Class A’s price target?

The average price target for Definitive Healthcare Corp. Class A is 4.50. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.00 ,the lowest forecast is $3.00. The average price target represents 9.76% Increase from the current price of $4.1.

What do analysts say about Definitive Healthcare Corp. Class A?

Definitive Healthcare Corp. Class A’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of DH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Definitive Healthcare Corp (DH) Stock Forecast & Price Target

DH Analyst Ratings

DH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Definitive Healthcare Corp

DH Analyst Recommendation Trends

DH Financial Forecast

DH Earnings Forecast

DH Sales Forecast

DH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts